Benefits of Tocilizumab in patients with a severe form of SARS-CoV-2 infection: Experience of the intensive care unit of the Mohammed VI university hospital, Oujda

BACKGROUND: COVID-19 is a new disease that appeared in December 2019. Millions of people have been infected and died from this infection. Until today, the pathophysiology and treatment of this infection remain unknown, but a lot of studies are trying to solve the mystery. The trail of inflammation r...

Descripción completa

Detalles Bibliográficos
Autores principales: El Rhalete, Abdelilah, Rhazi, Inas, Bensaid, Amine, Diass, Soufiane, Kaouini, Abderrahim, Ounci, Essaad, Abdi, Mohammed, Maarad, Mohammed, Babouh, Choukri, Alami, Zineb, Abda, Naima, Bkiyer, Houssam, Housni, Brahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233060/
https://www.ncbi.nlm.nih.gov/pubmed/34221397
http://dx.doi.org/10.1016/j.amsu.2021.102514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233060/
https://www.ncbi.nlm.nih.gov/pubmed/34221397
http://dx.doi.org/10.1016/j.amsu.2021.102514

Ejemplares similares